FRONDOSIDE A
The treatment is painless and many patients experience a noticeable improvement within 24 hours.
Treatment
Treatment with Frondoside A is administered intravenously over the course of 1 to 5 sessions. During these sessions, patients are monitored for allergic reactions or other side effects.
Innovate
An innovative option to accompany immunotherapy and radiotherapy and for treatments in neurodegenerative disorders
Neuroprotective
Multiple preclinical studies have shown that Frondoside A has promising neuroprotective and anticancer effects in a wide range of human cancer cell lines, including breast, lung, prostate, and leukemia.
Help
Modulates the immune response, helps reduce the side effects of chemotherapy, such as pain, fatigue or loss of appetite